Pulmonary arterial hypertension (PAH) has a multifactorial pathobiology. Vasoconstriction, remodeling of the pulmonary vessel wall, and thrombosis contribute to increased pulmonary …
Pulmonary hypertension is associated with diverse cardiac, pulmonary, and systemic diseases in neonates, infants, and older children and contributes to significant morbidity and …
Thus, the task of writing Guidelines or Expert Consensus documents covers not only the integration of the most recent research, but also the creation of educational tools and …
M Humbert, O Sitbon… - New England Journal of …, 2004 - Mass Medical Soc
Pulmonary arterial hypertension, which is characterized by vascular proliferation and remodeling of small pulmonary vessels, leads to a progressive increase in pulmonary …
N Galie, A Torbicki, R Barst, P Dartevelle… - European heart …, 2004 - academic.oup.com
Level of Evidence A Data derived from multiple randomised clinical trials or meta-analyses Level of Evidence B Data derived from a single randomised clinical trial or large non …
In less than 20 years, the first selective type 5 phosphodiesterase inhibitor, sildenafil, has evolved from a potential anti-angina drug to an on-demand oral treatment for erectile …
markers such as right atrial pressure, cardiac output, and mean PAP. 8 Importantly, this procedure has been shown to be safe, with no deaths reported in the National Institutes of …
EJ Tsai, DA Kass - Pharmacology & therapeutics, 2009 - Elsevier
Cyclic guanosine 3', 5'-monophosphate (cGMP) mediates a wide spectrum of physiologic processes in multiple cell types within the cardiovascular system. Dysfunctional signaling at …
EK Weir, J López-Barneo, KJ Buckler… - New England Journal …, 2005 - Mass Medical Soc
This review discusses recent advances in the understanding of the ways in which different organs detect and respond to acute changes in oxygen tension. A group of specialized …